About Avive
Avive is a company based in Brisbane (United States) founded in 2017 by Rory Beyer, Sameer Jafri, and Moseley Andrews. Avive has raised $110.65 million across 6 funding rounds from investors including IrishAngels, Questa Capital and Laerdal Million Lives Fund. Avive operates in a competitive market with competitors including HeartHero, Complient Corp, Nanoomtech, Cardiac Science and HeartSine, among others.
- Headquarter Brisbane, United States
- Founders Rory Beyer, Sameer Jafri, Moseley Andrews
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$110.65 M (USD)
in 6 rounds
-
Latest Funding Round
$56.71 M (USD), Series B
Feb 01, 2024
-
Investors
IrishAngels
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Avive
Unlock access to complete
Unlock access to complete
Funding Insights of Avive
Avive has successfully raised a total of $110.65M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $56.71 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avive
Avive has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include IrishAngels, Questa Capital and Laerdal Million Lives Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Investments are made in disruptive health technologies for life-saving impact.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Avive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avive
Investment portfolio details for Avive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avive
Detailed financials for Avive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avive Comparisons
Peer comparison for Avive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avive
Avive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HeartHero, Complient Corp, Nanoomtech, Cardiac Science and HeartSine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable automated external defibrillators are developed using AI technology.
|
|
| Locked | Locked | Locked |
Provides AEDs, CPR equipment, and training services.
|
|
| Locked | Locked | Locked |
Manufactures automatic defibrillator emergency rescue and medical equipment
|
|
| Locked | Locked | Locked |
Portfolio of Automated external defibrillators
|
|
| Locked | Locked | Locked |
Automated External Defibrillators are designed and manufactured by HeartSine.
|
Detailed competitors of Avive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avive
Complete news archive for Avive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avive
Avive was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Avive is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Sameer Jafri is the current CEO of Avive. They have also founded this company.
Avive is a funded company, having raised a total of $110.65M across 6 funding rounds to date.
Avive was founded in 2017 in Brisbane, United States, within the health technology sector. Next-generation automated external defibrillators and software solutions are provided to address sudden cardiac arrest. Operations center on medical device development and emergency response tools. The companys offerings support increased survival rates through integrated hardware and digital platforms, with a focus on accessibility in various geographic settings.
Avive's top competitors include HeartHero, Nanoomtech and HeartSine.
Avive has 11 investors. Key investors include IrishAngels, Questa Capital, Laerdal Million Lives Fund, CHV, and Eckuity.